Vol. 150, No. 51 — December 17, 2016
AWP HEALTH & LIFE SA
APPLICATION TO ESTABLISH A CANADIAN BRANCH
Notice is hereby given that AWP Health & Life SA, trading as Allianz Worldwide Care, Allianz Worldwide Partners, and Allianz Santé Internationale, an entity incorporated and formed under the laws of France, intends to file with the Superintendent of Financial Institutions, on or after January 3, 2017, an application under section 574 of the Insurance Companies Act (Canada) for an order approving the insuring in Canada of risks, under the names, in English, “AWP Health & Life SA”, “Allianz Worldwide Care” and “Allianz Worldwide Partners” and, in French, “AWP Santé & Vie SA” and “Allianz Santé Internationale”, within the following classes of insurance: accident and sickness insurance and life insurance. The head office of AWP Health & Life SA is located in Paris, France, and its Canadian chief agency will be located in Toronto, Ontario.
December 1, 2016
AWP Health & Life SA
By its solicitors
Dentons Canada LLP
VERSABANK AND PWC CAPITAL INC.
LETTERS PATENT OF AMALGAMATION
Notice is hereby given that, subject to approval by special resolution of their respective shareholders, VersaBank and PWC Capital Inc. intend to jointly apply to the Minister of Finance pursuant to subsection 228(1) of the Bank Act, on or after December 30, 2016, for letters patent of amalgamation continuing them as a bank under the Bank Act, under the name VersaBank. Its head office will be located in London, Ontario.
Note: The publication of this notice should not be construed as evidence that letters patent will be issued to amalgamate the applicants as a bank. The granting of the letters patent will be dependent upon the normal Bank Act application review process and the discretion of the Minister of Finance.
November 22, 2016
VSP CANADA VISION CARE INSURANCE
REDUCTION OF STATED CAPITAL
As required under subsection 79(5) of the Insurance Companies Act (the “Act”), notice is hereby given that VSP Canada Vision Care insurance (the “Company”) intends to apply to the Superintendent of Financial Institutions (Canada) for approval to reduce the stated capital of the common shares of the Company in accordance with the special resolution passed by the sole shareholder of the Company on November 16, 2016, a copy of which is set out below.
“RESOLVED as a Special Resolution:
- That the Company be and is hereby authorized to reduce from $9,300,000 to $5,800,000 the amount of the stated capital account maintained for the Common shares of the Company, by distributing an amount of CAD$3,500,000 to the sole holder of the Common shares;
- That the Company arrange for a copy of this resolution, together with a notice of intention to apply to the Superintendent for approval of said reduction of its stated capital, to be published in the Canada Gazette, Part I, as required under subsection 79(5) of the Act;
- That, after such publication has been made, the Company apply to the Superintendent for approval of said reduction of its stated capital pursuant to subsection 79(5) of the Act;
- That any director or any officer of the Company be and is hereby authorized, for, on behalf of, and in the name of the Company, to sign and deliver any and all notices or other documents and to do such other acts and things as may be considered necessary or desirable to give effect to this Special Resolution.”
Montréal, November 16, 2016
Maren Martinelli Christie